Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 27.
doi: 10.1111/ijd.17909. Online ahead of print.

What is the Verdict? A Systematic Review of Dupilumab and Lichen Planus

Affiliations

What is the Verdict? A Systematic Review of Dupilumab and Lichen Planus

Anagha Srivatsa et al. Int J Dermatol. .
No abstract available

Keywords: PD‐1 inhibitor; drug‐induced lichen planus; dupilumab; immunotherapy; lichen planus; lichen planus pemphigoides; lichenoid drug eruption.

PubMed Disclaimer

References

    1. K. Boch, E. A. Langan, K. Kridin, D. Zillikens, R. J. Ludwig, and K. Bieber, “Lichen Planus,” Frontiers in Medicine 8 (2021): 737813.
    1. S. Kazemi, M. Murphrey, and J. E. Hawkes, “Rapid Resolution of Widespread Cutaneous Lichen Planus and Generalized Pruritus in an Elderly Patient Following Treatment With Dupilumab,” JAAD Case Reports 30 (2022): 108–110.
    1. S. Z. Li, Y. H. Xie, S. H. Wang, R. Y. Fang, H. Z. Jin, and Y. G. Zuo, “Case Report: Successful Treatment of Non‐Bullous Lichen Planus Pemphigoides With Dupilumab,” Frontiers in Medicine 9 (2022): 1023458.
    1. T. E. Kim and M. K. Shin, “De Novo Case of Lichenoid Eruption Following Dupilumab Treatment,” JAAD Case Reports 13 (2021): 71–72.
    1. L. Kern, L. Kleinheinrich, R. Feldmann, P. Sator, A. Stella, and F. Breier, “Dupilumab‐Induced Lichen Planus: A Case With Oral and Cutaneous Eruptions,” Case Reports in Dermatology 14, no. 3 (2022): 356–361.

LinkOut - more resources